Diane Seimetz
Director/Board Member at HUMACYTE, INC.
Net worth: - $ as of 29/04/2024
Diane Seimetz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| HUMACYTE, INC. | Director/Board Member | 08/06/2022 | - |
| Independent Dir/Board Member | 08/06/2022 | - | |
Children's Advocacy Center of Collin County, Inc.
 Children's Advocacy Center of Collin County, Inc. Services to the Health IndustryHealth Services Children's Advocacy Center of Collin County, Inc. is a non-profit organization. which provides safety, healing, and justice for the children who suffered in child abuse. It offers forensic interviews, family advocacy and support services, therapeutic counseling, and community education. The company was founded in 1992 and is headquartered in Plano, TX. | Director/Board Member | - | - |
Cumulus Oncology Ltd.
 Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Director/Board Member | - | - |
MyoPax GmbH
 MyoPax GmbH BiotechnologyHealth Technology MyoPax GmbH is a biotech start-up located in Germany and Denmark that focuses on innovative regenerative therapies for muscle disorders. The German company was spun out of the Charité Universitätsmedizin and the Max Delbrück Center in the Helmholtz Association and joined the BioInnovation Institute in Copenhagen with pre-seed funding. MyoPax leverages its proprietary muscle stem cell technology and cutting-edge gene editing technologies to transform the treatment landscape and improve the quality of life for patients affected by muscle disorders. | Director/Board Member | 31/12/2021 | - |
| Founder | 31/12/2021 | - |
Career history of Diane Seimetz
Former positions of Diane Seimetz
| Companies | Position | Start | End |
|---|---|---|---|
Launch Agency LP
 Launch Agency LP Advertising/Marketing ServicesCommercial Services Launch Agency LP provides marketing and interactive communications services. The company was founded in 2003 and is headquartered in Carrolton, TX. | Founder | 31/12/2002 | - |
| Corporate Officer/Principal | 11/10/2011 | - |
Training of Diane Seimetz
| Universität des Saarlandes | Undergraduate Degree |
| University of Bonn | Graduate Degree |
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistics
International
| Germany | 5 |
| United States | 4 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 4 |
| Founder | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| HUMACYTE, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Launch Agency LP
Launch Agency LP Advertising/Marketing ServicesCommercial Services Launch Agency LP provides marketing and interactive communications services. The company was founded in 2003 and is headquartered in Carrolton, TX. | Commercial Services |
Children's Advocacy Center of Collin County, Inc.
Children's Advocacy Center of Collin County, Inc. Services to the Health IndustryHealth Services Children's Advocacy Center of Collin County, Inc. is a non-profit organization. which provides safety, healing, and justice for the children who suffered in child abuse. It offers forensic interviews, family advocacy and support services, therapeutic counseling, and community education. The company was founded in 1992 and is headquartered in Plano, TX. | Health Services |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
MyoPax GmbH
MyoPax GmbH BiotechnologyHealth Technology MyoPax GmbH is a biotech start-up located in Germany and Denmark that focuses on innovative regenerative therapies for muscle disorders. The German company was spun out of the Charité Universitätsmedizin and the Max Delbrück Center in the Helmholtz Association and joined the BioInnovation Institute in Copenhagen with pre-seed funding. MyoPax leverages its proprietary muscle stem cell technology and cutting-edge gene editing technologies to transform the treatment landscape and improve the quality of life for patients affected by muscle disorders. | Health Technology |
- Stock Market
- Insiders
- Diane Seimetz
- Experience